Competitive amplification of differentially melting amplicons (CADMA) improves KRAS hotspot mutation testing in colorectal cancer

Overview of attention for article published in BMC Cancer, November 2012

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Good Attention Score compared to outputs of the same age and source (66th percentile)

Mentioned by

policy: 1 policy source

Citations

dimensions_citation: 11 Dimensions

Readers on

mendeley: 18 Mendeley

Summary Policy documents Dimensions citations

So far, Altmetric has seen 1 policy document that references this research output.

KRAS Testing for Metastatic Colorectal Cancer Using Therascreen KRAS RGQ PCR Kit

Cited by Canadian Agency for Drugs and Technologies in Health on 15 May 2014

CADTH is an independent, not-for-profit organization responsible for providing health care decision-makers with objective evidence to help make informed decisions about the optimal use of health technologies.

This page shows the most recent policy documents that mention this research output.

Click here to find out how to access more activity.